These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 37150737)

  • 1. Characteristics of prostate cancer patients captured by facility-based versus geography-based cancer registries.
    Modi PK; Ward KC; Filson CP
    Urol Oncol; 2023 Jul; 41(7):324.e1-324.e7. PubMed ID: 37150737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of breast, colorectal, lung, and prostate cancers reported to the National Cancer Data Base and the Surveillance, Epidemiology, and End Results Program.
    Mettlin CJ; Menck HR; Winchester DP; Murphy GP
    Cancer; 1997 May; 79(10):2052-61. PubMed ID: 9149035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined External Beam Radiation Therapy and Brachytherapy versus Radical Prostatectomy with Adjuvant Radiation Therapy for Gleason 9-10 Prostate Cancer.
    Muralidhar V; Mahal BA; Butler S; Lamba N; Yang DD; Leeman J; D'Amico AV; Nguyen PL; Trinh QD; Orio PF; King MT
    J Urol; 2019 Nov; 202(5):973-978. PubMed ID: 31144590
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increasing rate of pathologic upgrading in low risk prostate cancer patients in the active surveillance era.
    Davaro F; Weinstein D; Wong R; Siddiqui S; Hinyard L; Hamilton Z
    Can J Urol; 2022 Apr; 29(2):11059-11066. PubMed ID: 35429423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current use of active surveillance in an Australian cohort of men: a pattern of care analysis from the Victorian Prostate Cancer Registry.
    Weerakoon M; Papa N; Lawrentschuk N; Evans S; Millar J; Frydenberg M; Bolton D; Murphy DG
    BJU Int; 2015 Apr; 115 Suppl 5():50-6. PubMed ID: 25601201
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of lymph node metastases in pathological gleason score≤6 prostate adenocarcinoma: Analysis of institutional and population-based databases.
    Wenger H; Weiner AB; Razmaria A; Paner GP; Eggener SE
    Urol Oncol; 2017 Jan; 35(1):31.e1-31.e6. PubMed ID: 27692833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalizability of the Prostate Cancer Intervention Versus Observation Trial (PIVOT) Results to Contemporary North American Men with Prostate Cancer.
    Dalela D; Karabon P; Sammon J; Sood A; Löppenberg B; Trinh QD; Menon M; Abdollah F
    Eur Urol; 2017 Apr; 71(4):511-514. PubMed ID: 27638094
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disparities in Hispanic/Latino and non-Hispanic Black men with low-risk prostate cancer and eligible for active surveillance: a population-based study.
    Katz JE; Chinea FM; Patel VN; Balise RR; Venkatramani V; Gonzalgo ML; Ritch C; Pollack A; Parekh DJ; Punnen S
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):533-538. PubMed ID: 29988097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inverse stage migration patterns in North American patients undergoing local prostate cancer treatment: a contemporary population-based update in light of the 2012 USPSTF recommendations.
    Leyh-Bannurah SR; Karakiewicz PI; Pompe RS; Preisser F; Zaffuto E; Dell'Oglio P; Briganti A; Nafez O; Fisch M; Steuber T; Graefen M; Budäus L
    World J Urol; 2019 Mar; 37(3):469-479. PubMed ID: 29992380
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The National Cancer Data Base report on prostate carcinoma after the peak in incidence rates in the U.S. The American College of Surgeons Commission on Cancer and the American Cancer Society.
    Mettlin CJ; Murphy GP; Rosenthal DS; Menck HR
    Cancer; 1998 Oct; 83(8):1679-84. PubMed ID: 9781963
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent time trends in the epidemiology of stage IV prostate cancer in the United States: analysis of data from the Surveillance, Epidemiology, and End Results Program.
    Cetin K; Beebe-Dimmer JL; Fryzek JP; Markus R; Carducci MA
    Urology; 2010 Jun; 75(6):1396-404. PubMed ID: 19969335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional differences in patient age and prostate cancer characteristics and rates of treatment modalities in favorable and unfavorable intermediate risk prostate cancer across United States SEER registries.
    Wenzel M; Collà Ruvolo C; Nocera L; Würnschimmel C; Tian Z; Shariat SF; Saad F; Briganti A; Graefen M; Becker A; Mandel P; Chun FKH; Karakiewicz PI
    Cancer Epidemiol; 2021 Oct; 74():101994. PubMed ID: 34364187
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in active surveillance for very low-risk prostate cancer: do guidelines influence modern practice?
    Parikh RR; Kim S; Stein MN; Haffty BG; Kim IY; Goyal S
    Cancer Med; 2017 Oct; 6(10):2410-2418. PubMed ID: 28925011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physician variation in management of low-risk prostate cancer: a population-based cohort study.
    Hoffman KE; Niu J; Shen Y; Jiang J; Davis JW; Kim J; Kuban DA; Perkins GH; Shah JB; Smith GL; Volk RJ; Buchholz TA; Giordano SH; Smith BD
    JAMA Intern Med; 2014 Sep; 174(9):1450-9. PubMed ID: 25023650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The National Cancer Data Base report on patterns of childhood cancers in the United States.
    Grovas A; Fremgen A; Rauck A; Ruymann FB; Hutchinson CL; Winchester DP; Menck HR
    Cancer; 1997 Dec; 80(12):2321-32. PubMed ID: 9404710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Geographic Distribution of Racial Differences in Prostate Cancer Mortality.
    Fletcher SA; Marchese M; Cole AP; Mahal BA; Friedlander DF; Krimphove M; Kilbridge KL; Lipsitz SR; Nguyen PL; Choueiri TK; Kibel AS; Trinh QD
    JAMA Netw Open; 2020 Mar; 3(3):e201839. PubMed ID: 32232449
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostate cancer in Pennsylvania: The role of older age at diagnosis, aggressiveness, and environmental risk factors on treatment and mortality using data from the Pennsylvania Cancer Registry.
    Bluethmann SM; Wang M; Wasserman E; Chen C; Zaorsky NG; Hohl RJ; McDonald AC
    Cancer Med; 2020 May; 9(10):3623-3633. PubMed ID: 32212232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study.
    Moschini M; Fossati N; Sood A; Lee JK; Sammon J; Sun M; Pucheril D; Dalela D; Montorsi F; Karnes RJ; Briganti A; Trinh QD; Menon M; Abdollah F
    Eur Urol Focus; 2018 Jan; 4(1):68-74. PubMed ID: 28753764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of Cancer Specific Mortality with Surgery versus Radiation as Primary Therapy for Localized High Grade Prostate Cancer in Men Younger Than 60 Years.
    Huang H; Muscatelli S; Naslund M; Badiyan SN; Kaiser A; Siddiqui MM
    J Urol; 2019 Jan; 201(1):120-128. PubMed ID: 30059685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of high and very high dose radiotherapy after radical prostatectomy for prostate cancer in the United States.
    Alexidis P; Guo W; Bekelman JE; Vapiwala N; Gabriel PE; Christodouleas JP
    Prostate Cancer Prostatic Dis; 2018 Nov; 21(4):584-593. PubMed ID: 30087427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.